Most Clicked StoriesMore >


$217M raised for startup aimed at battling neurodegenerative diseases

FasterCures SmartBrief | May 19, 2015

Three former Genentech researchers are starting a company to study treatments for neurodegenerative diseases thanks to $217 million in venture capital. Denali Therapeutics will look closely at such diseases as Alzheimer's, ALS and Parkinson's. "The science in the field has been breaking open and this has been accelerating over the past decade. Denali is based on the idea that the time is right to tackle these diseases systematically and deeply," said neuroscientist and co-founder Marc Tessier-Lavigne. Forbes (05/14)


New Milken Institute unit maximizes strategic philanthropy

FasterCures SmartBrief | May 21, 2015

Register for June 9 webinar on patient registries

FasterCures SmartBrief | May 21, 2015

Guidance on using adaptive design in medical device studies issued by FDA

FasterCures SmartBrief | May 19, 2015

Funding for gene therapies makes a comeback

FasterCures SmartBrief | May 21, 2015

Prototype microscope able to see deep into the brain

FasterCures SmartBrief | May 19, 2015

The biggest risks confronting biotech stock investors

FasterCures SmartBrief | May 19, 2015

Gene editing restores fetal hemoglobin in lab study of sickle cell anemia

FasterCures SmartBrief | May 19, 2015

Researchers develop device to isolate clusters of cancer cells in blood

FasterCures SmartBrief | May 19, 2015

Register for FasterCures' Value and Coverage workshop, June 11 in Washington

FasterCures SmartBrief | May 19, 2015


Find FasterCures SmartBrief Issues by Date:



FASTERCURES News More >


Save the date for Partnering for Cures

FasterCures SmartBrief | May 21, 2015

Register for June 9 webinar on patient registries

FasterCures SmartBrief | May 21, 2015

Register for FasterCures' Value and Coverage workshop, June 11 in Washington

FasterCures SmartBrief | May 19, 2015

Save the date for Partnering for Cures: Nov. 1-3, 2015

FasterCures SmartBrief | May 14, 2015

Survey explores structure of IP provisions

FasterCures SmartBrief | May 12, 2015




Sign up for FasterCures SmartBrief



Designed specifically for those in pursuit of medical solutions, FasterCures SmartBrief is a FREE twice-weekly newsletter. Providing targeted news from hundreds of top industry sources, FasterCures SmartBrief keeps you informed about important medical solutions news. Learn more